MorphoSys AG (NASDAQ:MOR) Receives Consensus Rating of Hold from Analysts

Shares of MorphoSys AG (NASDAQ:MOR – Get Rating) have earned an average rating of “Hold” from the fourteen research firms that are covering the company, MarketBeat reports. Eleven investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price target among brokers […]

Related Keywords

United States , ,Morgan Stanley ,Berenberg Bank ,Zacks Investment Research ,Blackrock Inc ,Alphacentric Advisors ,Morphosys Company Profile Get Rating ,Cubist Systematic Strategies ,Citigroup ,Get Rating ,Investment Research ,Systematic Strategies ,Sys Company Profile ,Morphosys ,Nasdaq Mor ,Humor ,Medical ,Ratings ,Consensus ,